Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,985 active trials259 approved drugs4,032 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00274911 | Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors | unknown | Phase 2 | 30 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 2, 2013 | clinicaltrials |
| NCT00720447 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | unknown | Phase 2 | 25 | Cancer Research UKOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00886717 | Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 1 / Phase 2 | 74 | Asan Medical CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00893477 | GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | unknown | Phase 2 | 60 | French Innovative Leukemia OrganisationOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00896519 | GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma | unknown | Phase 2 | 30 | French Innovative Leukemia OrganisationOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00907036 | Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma | unknown | Phase 2 | 49 | Cancer Research UKOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | unknown | Phase 2 | 47 | Cancer Research UKOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT01914458 | Image Discovering Early Lung Cancer Project(IDEALCAP) | unknown | Phase 2 | 600 | Cathay General HospitalOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01914744 | Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL | unknown | Phase 2 | 82 | Fudan UniversityOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01854203 | Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC(NPC) | unknown | Phase 2 / Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT01909388 | Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy(BRAPROST) | unknown | Phase 2 | 15 | Alfonso Gomez-IturriagaOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT01728389 | Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. | unknown | Phase 1 / Phase 2 | 10 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01598402 | Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia(PANTAP) | unknown | Phase 2 / Phase 3 | 106 | Radboud University Medical CenterOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT01898962 | Definitive Therapy for Oligometastatic Solid Malignancies | unknown | Phase 2 | 110 | Rocky Mountain Cancer CentersOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT01899118 | Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT01185145 | Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy(APBI) | unknown | Phase 2 | 291 | Rocky Mountain Cancer CentersOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01895010 | Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE | unknown | Phase 2 | 74 | Fudan UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT01887561 | Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial | unknown | Phase 2 | 100 | Kanto CML Study GroupOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT01881516 | Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue(CRF) | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 0 | Jun 19, 2013 | clinicaltrials |
| NCT01872416 | A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT01871688 | Pelvic Floor Rehabilitation for Gynecological Cancer Patients | unknown | Phase 2 / Phase 3 | 100 | Seoul National University Bundang HospitalOTHER | 1 | Jun 7, 2013 | clinicaltrials |
| NCT01872403 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung | unknown | Phase 2 | 120 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 7, 2013 | clinicaltrials |
| NCT01871363 | Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer | unknown | Phase 2 | 35 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT01861912 | Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma(ACTION) | unknown | Phase 2 / Phase 3 | 258 | Guangdong Provincial People's HospitalOTHER | 0 | Jun 5, 2013 | clinicaltrials |
| NCT01695590 | Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma | unknown | Phase 1 / Phase 2 | 40 | Prolexys PharmaceuticalsINDUSTRY | 1 | Jun 4, 2013 | clinicaltrials |
| NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 86 | National Health Research Institutes, TaiwanOTHER | 0 | Jun 4, 2013 | clinicaltrials |
| NCT01866670 | Effect of the Nursing Intervention "Spiritual Support" | unknown | Phase 2 | 25 | University of Sao PauloOTHER | 1 | May 31, 2013 | clinicaltrials |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | unknown | Phase 2 | 60 | Shi-Ming LinOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01830556 | Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck(CETMET) | unknown | Phase 2 | 120 | Karolinska University HospitalOTHER | 2 | May 21, 2013 | clinicaltrials |
| NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | unknown | Phase 2 | 90 | Aichi Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01463501 | Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT01849939 | Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia(RICAC) | unknown | Phase 2 | 43 | University Hospital, Clermont-FerrandOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT01850147 | Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT01798251 | XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach | unknown | Phase 2 | 40 | Harbin Medical UniversityOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | unknown | Phase 1 / Phase 2 | 40 | Fudan UniversityOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT01839539 | Study of DC-CIK to Treat Colorectal Cancer | unknown | Phase 2 | 60 | Guangxi Medical UniversityOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT00930566 | Extracorporal Photopheresis Pilot Study(ECP) | unknown | Phase 1 / Phase 2 | 20 | Hospices Civils de LyonOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01154270 | CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMIC(COSMIC) | unknown | Phase 2 | 54 | Heidelberg UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01192087 | Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy(ACCEPT) | unknown | Phase 1 / Phase 2 | 49 | Heidelberg UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01368419 | Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients | unknown | Phase 2 | 40 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01410370 | Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases | unknown | Phase 2 | 80 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01836991 | D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer | unknown | Phase 2 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT01836120 | A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Apr 19, 2013 | clinicaltrials |
| NCT01832948 | Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT01821482 | A Study of DC-CIK to Treat Hepatocellular Carcinoma | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01821495 | Study of DC-CIK to Treat NPC | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01830478 | Lenalidomide Plus Rituximab (R) in Non Follicular NHL | unknown | Phase 2 | 44 | Gruppo Italiano Studio LinfomiOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01503502 | A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | unknown | Phase 2 | 150 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01826396 | Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer | unknown | Phase 2 | 100 | Colorectal Cancer Institute of the Heilongjiang Academy of Medical SciencesOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT01686386 | Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma | unknown | Phase 1 / Phase 2 | 60 | Gruppo Italiano Studio LinfomiOTHER | 1 | Apr 5, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Aug 2, 2013source: clinicaltrials